Home » Blog » Clinical Articles » In Depth Articles » Guidelines for treating SCCs and BCCs

Guidelines for treating SCCs and BCCs

The latest updated version of the clinical practice guidelines for keratinocyte cancer are now available and worth checking out, especially if you do a lot of skin work.

Keratinocyte cancer is the new way to talk about non-melanoma skin cancer and basically refers to basal cell carcinomas and squamous cell carcinomas.

The new guidelines, which were developed by an Australian ‘non-remunerated working group’, incorporate a number of recent developments in the non-surgical treatment of these cancers. They provide suitable options for treating more advanced and metastatic cancers, and give guidance on how to manage patients who are believed to be at greater risk of developing these cancers, eg those who are on immunosuppression therapy.

These particular guidelines have come in for some criticism as they seem to be very quick to recommend referral to a non-GP specialist, but that aside, the principles of treatment are important irrespective of who delivers the treatment.

In addition to treatment, the guidelines also lay out the latest evidence-based recommendations for diagnosis and prevention of these skin cancers, although these recommendations are relatively unchanged from the previous version which was published in 2008.

These guidelines are the latest to be put out by the Cancer Council Australia’s Clinical Guidelines Network (formerly Australian Cancer Network). It is a service provided by Cancer Council Australia to inform clinical practice and ultimately improve cancer management in Australia.

We all know skin cancer is very common in Australia. Having a resource such as this at our fingertips should be considered a great support for every practising GP.

>> Access the resource here